Table 2.

Univariate risk factors for mortality among study participants

Patient characteristic	Number of deaths/N	% Mortality	Odds ratio (95% CI)	P-value
Observational cohort	14/1,140	1.2	1.0
Clinical trial cohort	4/527	0.8	0.6 (0.2, 1.9)	0.40
Age 12–59 mo	4/927	0.4	1.0
Age 2–11 mo	14/740	1.9	4.5 (1.5, 13.7)	0.004
Female	8/692	1.2	1.0
Male	10/964	1.0	0.9 (0.4, 2.3)	0.8
Immunization not up to date	3/92	3.3	1.0
Immunization up to date	15/1,434	1.1	0.3 (0.1, 1.1)	0.06
Duration of symptoms < 3 days	10/1,174	0.4	1.0
Duration of symptoms ≥3 days	8/493	1.6	4.0 (1.2, 13.9)	0.02
Weight-for-age Z score ≥2SD	11/1,334	0.8	1.0
Weight-for-age Z score <−2SD	4/212	1.9	2.3 (0.7, 7.3)	0.14
No history of wheeze	11/899	1.2	1.0
History of wheeze	1/259	0.4	0.3 (0.0, 2.4)	0.24
Pallor absent	14/1,471	1.0	1.0
Pallor present	2/71	2.8	3.0 (0.7, 13.6)	0.13
Dehydration absent	16/1,537	1.0	1.0
Dehydration present	2/130	1.5	1.5 (0.3, 6.5)	0.60
District hospital	9/1,184	0.8	1.0
Provincial hospital	9/451	2.0	2.7 (1.1, 6.8)	0.03

Abbreviation: CI, confidence interval.